Study proposes repurposed drug to treat COVID-19
The drug is now in Phase-II trials to evaluate efficacy, safety, tolerability to treat COVID-19 patients
The drug is now in Phase-II trials to evaluate efficacy, safety, tolerability to treat COVID-19 patients